Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Tonghua Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7015-5348; OpenAlex author ID A5103007199. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 4 papers · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper

Papers 10

  1. Upregulation of exosomal microRNA‑21 in pancreatic stellate cells promotes pancreatic cancer cell migration and enhances Ras/ERK pathway activity. Last author DOI 10.3892/ijo.2020.4986↗
  2. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation. Co-author DOI 10.1016/j.canlet.2019.07.015↗
  3. Upregulation of nucleoprotein AHNAK is associated with poor outcome of pancreatic ductal adenocarcinoma prognosis via mediating epithelial-mesenchymal transiti… Last author DOI 10.7150/jca.31291↗
  4. PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay. Last author DOI 10.1186/s13000-017-0678-4↗
  5. Retraction: PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation. Last author DOI 10.18632/oncotarget.25033↗
  6. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrin… Last author DOI 10.1016/j.canlet.2017.04.001↗
  7. Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s13000-017-0633-4↗
  8. PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation. Last author DOI 10.18632/oncotarget.20552↗
  9. SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axis. Last author DOI 10.3892/ijo.2017.4111↗
  10. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells. Last author DOI 10.18632/oncotarget.3099↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiyong Liang · 10 shared papers, 2015–2020 · strength 0.88
  2. Huanwen Wu · 8 shared papers, 2015–2020 · strength 0.67
  3. Qiang Ma · 5 shared papers, 2017–2020 · strength 0.48
  4. Ying Xiao · 4 shared papers, 2017–2020 · strength 0.39
  5. Junliang Lu · 4 shared papers, 2017–2019 · strength 0.32
  6. Li Wang · 3 shared papers, 2015–2017 · strength 0.21
  7. Zhiwen Zhang · 2 shared papers, 2018–2019 · strength 0.19
  8. Lili Wang · 2 shared papers, 2017–2018 · strength 0.16
  9. Hui Zhang · 2 shared papers, 2015–2017 · strength 0.13
  10. Xiaoding Liu · 1 shared paper, 2019 · strength 0.11
  11. Lianyuan Yu · 1 shared paper, 2019 · strength 0.08
  12. Xiaolong Liang · 1 shared paper, 2018 · strength 0.08
  13. Jian Hua Sun · 1 shared paper, 2018 · strength 0.08
  14. Junchao Guo · 1 shared paper, 2018 · strength 0.08
  15. Lili Wang · 1 shared paper, 2017 · strength 0.08
  16. Jian Guan · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.